http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008108477-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14 |
| filingDate | 2006-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008108477-A |
| titleOfInvention | NEW ANTIBACTERIAL COMPOUNDS |
| abstract | 1. A compound selected from the group comprising a compound of formula I! ! where! R1 is CH2NHCOR5, heteroarylmethyl, heteroaryloxymethyl or heteroarylaminomethyl! R2 means H, OH, OSO3H, ORO3H2, OCH2ORO3H2, OCOCH2CH2COOH or OCOR6,! R3 means H or halogen,! R4 is C1-C3 alkyl, C1-C3 haloalkyl or cycloalkyl! R5 means alkyl or halogenated, and! R6 means a residue of a natural amino acid or dimethylaminoglycine, and a prodrug, tautomer, optically pure enantiomer, mixture of enanatiomers, racemate, optically pure diastereoisomer, mixture of diastereoisomers, diastereoisomeric racemate, mixtures of diastereoisomeric racemates, a mesoform, a salt solution, a morphoid, a morphoid compound, a morphoid, a morphoid, a salt, a morphine compound, a morphoid, a morphine, a morphine, a morphine, a morphine, a morphine, a morphine, a morphine, a morphine, a morphine, a morphine, a morphoid, a salt, a morphine, a morphine, a morphoid, a salt, a morphine, a morphine, a morphine, a salt, a morphoid, a morphine, a morphine, a morphine, a salt, morphine, morphine. ! 2. The compound according to claim 1, in which R1 means CH2NHCOR5. ! 3. The compound according to claim 1, in which R1 means heteroarylmethyl. ! 4. The compound according to claim 3, in which R1 is 1,2,3-triazol-1-ylmethyl, 1,2,4-triazol-1-ylmethyl, pyrazol-1-ylmethyl, imidazol-1-ylmethyl or tetrazol- 1-ylmethyl. ! 5. The compound according to claim 1, in which R2 means OH, OPO3H2 or OCOR6. ! 6. The compound according to claim 5, in which R2 means OH. ! 7. The compound according to claim 1, in which R3 means halogen. ! 8. The compound according to claim 1, in which R4 means C1-C3 alkyl or cycloalkyl. ! 9. The compound according to claim 1, which is selected from the group including! - (16S, 13S) -1-cyclopropyl-7-fluoro-16- [2-fluoro-4 - ((5R) -2-oxo-5- [1,2,3] triazol-1-ylmethyloxazolidin-3- il) phenoxymethyl] -16-hydroxy-4-oxo-1,4,13,15,16,17-hexahydro-12H-11-oxa-1,14-diazacyclopenta [a] phenanthrene-3-carboxylic acid,! - (16S, 13S) -16- {4 - [(5S) - (acetylaminomethyl) -2-oxooxazolidin-3-yl] -2-fluorophenoxymethyl} -1-cyclopropyl-7-fluoro-16-hydroxy-4-oxo -1,4,13,15,16,17-hexahydro-12H-11-oxa-1,14-diazacyclopenta [a] phenanthrene-3-carboxylic acid,! - (16S, 13R) -16- {4 - [(5S) -5- (atets� |
| priorityDate | 2005-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.